Antiproliferative effects of bilirubin, heme metabolites, and heme oxygenase expression on colon and pancreatic cancer.
Public support
Provider
Ministry of Education, Youth and Sports
Programme
KONTAKT
Call for proposals
KONTAKT 4 (SMSM200600ME1)
Main participants
—
Contest type
VS - Public tender
Contract ID
2783/2009-32
Alternative language
Project name in Czech
Antiproliferační účinky bilirubinu, metabolitů hemu a exprese hemoxygenázy na karcinomu tlustého střeva a pankreatu
Annotation in Czech
detailní studium úlohy metabolismu bilirubinu v patogenezi kolorektálního a pankreatického karcinomu, základní výzkum, dataázový výzkum
Scientific branches
R&D category
AP - Applied research
CEP classification - main branch
FD - Oncology and haematology
CEP - secondary branch
—
CEP - another secondary branch
—
OECD FORD - equivalent branches <br>(according to the <a href="http://www.vyzkum.cz/storage/att/E6EF7938F0E854BAE520AC119FB22E8D/Prevodnik_oboru_Frascati.pdf">converter</a>)
30204 - Oncology<br>30205 - Hematology
Completed project evaluation
Provider evaluation
V - Vynikající výsledky projektu (s mezinárodním významem atd.)
Project results evaluation
Novel methods for investigation of bile pigment metabolism were stablished. Anticancer effects of bile pigments and carbon monoxide were proved on experimental models of pancreatic cancer. Relationship between genes controlling sérum bilirubin levels andcolon cancer risk was elucidated.
Solution timeline
Realization period - beginning
Mar 1, 2006
Realization period - end
Mar 31, 2009
Project status
U - Finished project
Latest support payment
Feb 24, 2009
Data delivery to CEP
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data delivery code
CEP10-MSM-ME-U/01:1
Data delivery date
Jun 30, 2010
Finance
Total approved costs
2,890 thou. CZK
Public financial support
2,770 thou. CZK
Other public sources
0 thou. CZK
Non public and foreign sources
120 thou. CZK